Natural vs Programmed Frozen Embryo Transfer for Pregnancy
(NatPro Trial)
Trial Summary
What is the purpose of this trial?
NatPro is a two-arm, parallel-group, multi-center, randomized trial in which women undergoing frozen embryo transfer (FET) will be randomized to receive either a modified natural cycle (corpus luteum present) or a programmed cycle (corpus luteum absent).
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you can continue using thyroid medication if needed. If you have a rheumatologic disease requiring chronic systemic medications, you cannot participate in the trial.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, you can continue using thyroid medication if needed.
What data supports the idea that Natural vs Programmed Frozen Embryo Transfer for Pregnancy is an effective treatment?
The available research shows that both natural cycle (NC) and hormone therapy (HT) frozen embryo transfers are effective treatments. Some studies suggest that NC might be as good as or even better than HT for patients with regular cycles. This is because NC uses the body's natural hormones, which might lead to better outcomes. However, the research is still ongoing to determine which method is more effective overall. Both methods are simpler and less costly compared to other treatments like repeated fresh embryo transfers.12345
What data supports the effectiveness of this treatment for pregnancy?
What safety data exists for natural vs programmed frozen embryo transfer treatments?
The safety data for natural vs programmed frozen embryo transfer treatments includes studies on obstetric and neonatal risks, as well as obstetric complications and perinatal outcomes. One study suggests increased obstetric and neonatal risks in artificial cycles compared to modified natural cycles. Another study evaluates obstetric complications and perinatal outcomes in natural cycle (NC-FET) versus hormone therapy cycle (HT-FET), focusing on serum estradiol and progesterone levels. Additionally, there is concern about increased maternal and perinatal morbidity in hormone therapy protocols due to the lack of corpus luteum. Overall, these studies provide insights into the safety and risks associated with different frozen embryo transfer protocols.12578
Is frozen embryo transfer generally safe for humans?
Research suggests that there may be increased risks for mothers and newborns when using hormone therapy cycles (HT-FET) compared to natural cycles (NC-FET) for frozen embryo transfers. However, the safety of these methods can vary, and it's important to discuss individual risks with a healthcare provider.12578
Is the treatment Modified natural cycle, Programmed cycle a promising treatment for pregnancy?
How does the modified natural cycle treatment for frozen embryo transfer differ from other treatments?
The modified natural cycle (mNC) treatment for frozen embryo transfer is unique because it closely mimics a woman's natural menstrual cycle, potentially leading to a higher probability of pregnancy compared to hormonally manipulated or stimulated cycles. Unlike hormone replacement treatments, mNC involves minimal medication, reducing the risk of complications associated with the absence of the corpus luteum, which is important for hormone production during early pregnancy.12569
Research Team
Valerie Baker, MD
Principal Investigator
Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine
James Segars, MD
Principal Investigator
Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine
Eligibility Criteria
Women aged 18-41 with at least one high-quality or genetically tested blastocyst for IVF, a normal uterine cavity, regular ovulatory cycles, and a BMI <=40. They must be willing to undergo single embryo transfer and randomization to either modified natural or programmed cycle FET. Exclusions include use of donor oocytes, uncontrolled diabetes or hypertension, certain uterine anomalies, and systemic rheumatologic diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo up to 3 frozen embryo transfer cycles in either a modified natural or programmed cycle
Follow-up
Participants are monitored for preeclampsia and live birth outcomes during pregnancy and up to 6 weeks post-delivery
Treatment Details
Interventions
- Modified natural cycle
- Programmed cycle
Find a Clinic Near You
Who Is Running the Clinical Trial?
JHSPH Center for Clinical Trials
Lead Sponsor